Parenteral Drugs (india) Ltd Quarterly Result
Parenteral Drugs (India) Ltd
NSE: PDPL
Net Profit - Last Quarter
Parenteral Drugs (India) Ltd Quarterly Results Key Highlights
Parenteral Drugs (India) Ltd Quarterly Results Analysis
Market Price of Parenteral Drugs (India) Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 21 Aug 2023 | 3.39 |
| 14 Aug 2023 | 3.24 |
| 24 Jul 2023 | 3.09 |
| 17 Jul 2023 | 3.25 |
| 10 Jul 2023 | 3.42 |
| 03 Jul 2023 | 3.59 |
| 26 Jun 2023 | 3.77 |
| 19 Jun 2023 | 3.96 |
| 12 Jun 2023 | 3.85 |
| 05 Jun 2023 | 4.05 |
Historical Revenue of Parenteral Drugs (India) Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Parenteral Drugs (India) Ltd
Historical EBITDA of Parenteral Drugs (India) Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Parenteral Drugs (India) Ltd
Historical Net Profit of Parenteral Drugs (India) Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Parenteral Drugs (India) Ltd
Popular Search
About Parenteral Drugs (India) Ltd
- Parenteral Drugs (India) Limited was incorporated in 1983 as a private limited company.
- In 1989, the Company established their first unit to manufacture I V Fluids in Polypropylene containers with a capacity of 18 lakh bottles per annum.
- In March 1994, the company was converted into a public limited company. Parenteral Drugs (India) is an India-based pharmaceutical company.
- The Company manufactures, and markets pharmaceutical products in India, including solid and liquid orals, such as antibiotics and anti-bacterial, anti-ulcerant, analgesics/anti-inflammatory, multivitamins and minerals, anxiolyic , antiprotozoal, anticold, anthelmintic, anti-histaminic, muscle relaxant, cardiac, antidiabetic, cough syrup, appetite enhancer and injections. The Company produces various therapeutic segments of In-Vitro (I V) Fluids, such as electrolytes, antibacterial, energy replenisher, irrigation solution, osmotic diuretic, dialysis solution.
